CAREER PROFILE:

• Professional with 17 years of strong Strategic Planning, Financial Modeling, Forecasting, Budgeting and Project Management experience in an International setting with focus on Europe and Asia
• Highly driven individual with a history of developing and presenting detailed and actionable analytics to Senior Executives and Decision makers in a Global environment through leveraging intimate knowledge of Pharmaceutical R & D, related Manufacturing processes, Financial analysis and Modeling processes to directly impact revenue stream and enhance overall pipeline value.
• Successful communicator known for bridging the initiatives of R & D science colleagues with the operational and budgetary constraints of the business units to arrive at mutually beneficial and actionable Budgets and Strategic plans.
• R & D Pipeline Valuation (NPV, IRR, ROI, Monte Carlo Simulation, Real Options and other statistical analysis methodologies/tools)
• Probability of Success (POS)/Risk Adjusted Scenario Analysis with Risk Mitigation strategies
• Molecule Specific Analytics in support of “Go/No Go” decisions for Sr. Late Development Review Committee (LDRC)
• Options Analysis for all R & D Capital Investments greater than $1MM
• Build multiple models for valuation of both Early and Late stage portfolios
• Develop TA specific erosion curves to better predict post Loss of Exclusivity (LOE) Sales - Market/Competitor analysis and response Strategy development
• Develop Long Range Operating Plan (LROP) & Long Range Capital Plan (LRCP)
• 10/20 Year Pipeline review and value enhancement
• Develop Licensing & Development models to assist with M & A negotiations
• Build Global Clinical Development Trials Flexible model - Global Resource Allocation ($150MM Savings)
• Build out consolidated Global Clinical Supplies and Sample (Cold storage) platform ($17MM plus savings)
• Develop forecasts and operating budgets ($5M to over $1.7B) and design dashboards to track performance and value metrics used in compensation models for Senior Confidential Leadership (VP through CEO)
• Pipeline Activity based cost development (both $ and Confidential resource requirement)
• Break down and quantify ($ & Confidential ) Pipe Line process to 127 specific activities from Discovery to Launch
• Develop Oncology specific paradigm to better plan for Oncology projects
• Develop process to better value MAbs (Monoclonal Antibodies) as compared to Small Molecules
• Develop POS adjustment criteria based on both internal and historical Pharma industry success data
• Develop process to track & promote the benefit of Adaptive Clinical trials vs. Standard Development
• Lead global cross-functional teams to successfully deliver multiple project using Six sigma processes/tools
• Manage Development, Testing, Face-to-Face training of 200 domestic and international colleagues and successful global launch of ReForM (Resource Forecasting Model - a Patent pending forecasting tool).
• Manage the integration of financial reporting and Grant of Authority process for J & J Pharmaceutical and Centocor Ortho Biotech resulting in seamless franchise reporting and faster project approval process
• Manage the process of vendor selection, $ negotiation with CROs and budget management for three large Clinical trials in Europe, Japan and Asia

COMPUTER / SOFTWARE SKILLS:

SAP. PeopleSoft, COGNOS, Business Objects and Financial /Statistical (Monte Carlo simulation) modeling MS Project/Word/Excel/PowerPoint/Access, Essbase, @Risk (simulation software) Windows/MAC environments, Database/IT Infrastructure Design and Development

EXPERIENCE:

Confidential, Bloomfield, CT

Sr. Finance Lead

Responsibilities:

• Develop Long/Short term budgets and Sales forecasts
• Develop models to support Strategy
• Develop business valuation models and provide recommendations and analysis to Management

Confidential, NY

Sr. Financial Analyst

Responsibilities:

• Develop Sales forecasts for new products/technologies based on input from Engineering and Business Development teams
• Develop business valuation models and provide recommendations and analysis to Management
• Provide M&A analysis and other ad-hoc scenario analysis

Project Manager

Confidential

Responsibilities:

• Take PLMs/ GroupLeader's high-level vision for a project and develop detailed analysis including Forecast/Budget, ROI, Activity level project plan (Six Sigma DMAIC, DESGN methodologies), explore multiple Options & Scenarios, negotiate resources as needed, consult with appropriate SMEs for opinions and present findings to Sponsor/Steering Team for Go/No-Go decision
• Develop all Project documentation from initial analysis and Senior presentation decks to Project Charter, Toll gate meetings, Project Close out and Sponsor survey documents
• Assemble, Lead cross-functional team and manage team dynamics across life cycle of project
• Manage Project Issues/Scope creep/ Scheduling conflicts/Status reports and presentations to Senior Leadership teams having ultimate responsibility for delivery of final work product on time and within budget

Confidential, Rahway, NJ

Finance Manager

Responsibilities:

• Lead modeling and related financial analysis activities for Confidential ’s roll out of the D-Model (Development Model) initiative targeted to produce $600MM plus in savings via out sourcing low value activities, acquiring niche technologies and load balancing key R&D activities across international sites
• Built sensitivity models with Monte Carlo simulation capabilities to answer management’s questions, “what-if” scenarios as well as risk mitigation strategies on the fly and present to Senior management
• Developed and lead all Financial analysis activities including modeling of Confidential ’s GRA initiative which targeted $150MM savings in 3 years (delivering ~$60MM savings in 2009 alone) by outsourcing and relocating clinical trials to low $ index countries
• Manage R&D Project valuation initiatives for the Neurology and BRIE franchises including building out NPV models and collaborating with Clinical, Manufacturing and Commercialization counterparts to develop detailed analysis for quarterly stage gate “Go, No-Go” reviews
• Evaluate all MRL Capital Investment projects <$1MM and provide synopsis and recommendations to Comptroller, delivering over $18MM in hard savings in 2009
• Work on multiple ad-hoc projects providing critical modeling and financial analysis support to companywide initiatives Site closure, CRO negotiations, develop Confidential burden rates and other Confidential pipeline specific analytics)

Confidential, Raritan, NJ

Senior Financial Analyst

Responsibilities:

• Manage ~$100MM budget supporting the Global Procrit/Eprex and other Oncology franchise initiatives and closing out 2007 with a 2.8% variance to annual budget
• Responsible for all aspects of forecasting, budgeting and reporting (SAP) monthly financial performance to VP of Procrit/Eprex Franchise and other products in the Oncology TA
• Assist multiple project teams with vendor negotiations, develop Clinical Budgets and responsible for all accruals and month end closes supporting multiple clinical project teams
• Lead GOA work stream in assisting with the overall financial integration activities between J&J and Centocor (a company acquired by J & J)
• Develop New Financial Dashboards to better enable monthly reporting to Management resulting in reducing monthly post close financial review meetings from 6 hours to ~ 2

Confidential, CT

Senior Financial Analyst

Responsibilities:

• Support budget teams during annual Confidential budgeting process ($1.7B project budget)
• Collaborate with Business Units within Confidential Finance to develop and support consistent tools processes for budget development and monthly reporting
• Spearheaded Licensing & Development costing effort for Development Finance Group in support of contract negotiations with potential M&A targets through modeling potential acquisition targets applying Monte Carlo simulations and multiple “Up Side/Down Side” scenarios
• Develop / model long/short term forecasts, annual operating plans, portfolio cost driver analysis and other pipeline strategy analysis for senior management as requested
• Direct build out and enhancement efforts of ReForM (Resource Forecasting Model), a top-down Human Health portfolio modeling tool including debugging and troubleshooting of output anomalies
• Lead redesign, testing, training and successful roll-out of web-based version of ReForM
• Successfully re-design and deliver Project Budget training to over 300 Confidential Finance & GPM colleagues

Confidential, NJ

Manager Finance & Operations

Responsibilities:

• Manage day-to-day finance operations, international fund transfers, forecasting, budgeting and long term financial planning
• Develop and maintain compensation models using Excel and Access for permanent/contract consultants, marketing and sales force
• Model financial (ROI, NAV, DCF etc.) and economic data for inclusion in feasibility and marketing reports to clients
• Collaborate with clients and management to plan IT strategy, conduct feasibility studies and perform financial analysis
• Monitor all software development projects, ensured deliverables were timely and milestone payments were received on time
• Assist management with long term strategy planning and market/competitor analysis
• Create and stream-line business and reporting processes

Confidential, Memphis, TN

Financial Analyst

Responsibilities:

• Carry out valuation of equity of privately held businesses, banks and other privately held entities for Employee Stock Option Plans (ESOPs), Estate and Tax planning purposes, Mergers and Acquisitions, and other corporate transactions
• Produced valuation reports and conducted industry, economic and market research
• Conducted on site interviews with senior management and related parties to develop detailed valuation reports and build strong working relationships with clients to develop further business opportunities
• Provide acquisition analysis & fairness opinions for transaction advisory division of the firm, creating Merger & Acquisition presentations (Play Book) for community bank shareholders and potential buyers
• Provide other transaction oriented consulting services to community banks and other business entities in various industries